Part 5/10:
Metabolites, which are substances produced during metabolism, serve as critical indicators of cancer's progression. Scientists have discovered that they provide significant insights into physiological states—normal or otherwise—and have shifted focus toward these metabolites as promising biomarkers. This new method utilizes advanced mass spectrometry and machine learning, enabling researchers to identify cancer's metabolic changes with remarkable accuracy.